RHY — Rhythm Biosciences Share News
0.000.00%
Last trade - 00:00- AU$22.94m
- AU$19.74m
- AU$1.74m
Brief: Rhythm Biosciences Says Rhythm Biosciences UK Limited Established
Australia's Rhythm Biosciences jumps after market entry into UK
Brief: Rhythm Biosciences Says Market Entry Of Colostat Into United Kingdom
Rhythm Biosciences sees best day in 3 yrs as cancer test device gets UK nod
Brief: Rhythm Biosciences Says CEO And Managing Director Glenn Gilbert Resigned
Australia's Rhythm Biosciences dives as co withdraws TGA application for cancer test-kit
Brief: Rhythm Biosciences Withdraws Current Colostat Application
Brief: Rhythm Biosciences Seeks Trading Halt
Brief: Rhythm Biosciences Posts HY Other Income From Ordinary Activities Of A$2.8 Million
Brief: Rhythm Biosciences Says Colostat® Authorised For Sale In New Zealand
Rhythm Biosciences jumps most in 7 months on New Zealand foray
Brief: Rhythm Biosciences Appoints Paul Smith As Chief Financial Officer
Brief: Rhythm Biosciences Ltd Confirms Director Share Sale To Institutional Funds Manager
Brief: Rhythm Biosciences FY Other Income From Ordinary Activities Up 118% To A$2.5 Mln
Brief: Rhythm Biosciences Files With TGA To List Colostat On Register Of Therapeutic Goods
Rhythm Biosciences soars on meeting primary endpoint for cancer detection test
Australia Stock Exchange release from RHYTHM BIOSCIENC : Cleansing Notice
Australia Stock Exchange release from RHYTHM BIOSCIENC : Application for quotation of securities - RHY
Australia Stock Exchange release from RHYTHM BIOSCIENC : S&P DJI Announces March 2022 Quarterly Rebalance